Biomarker diagnostic tests in precision medicine can stratify patient sub-populations into responders versus non-responders. Precision medicine’s promise is selecting the right drug for the ...

Janina Krumbeck, PhD, discusses the clinical advantages of next-generation sequencing over traditional culture and how this untargeted diagnostic approach provides comprehensive pathogen ...

The decreasing cost of DNA sequencing has contributed to an uptick in genomic sequencing for precision diagnostics in rare diseases. The future of precision medicine in rare diseases was explored in a ...

Cancer researchers and clinicians are driven by a shared goal – to improve patient quality of life and survival by developing and implementing the most effective treatments and diagnostic tools. Given ...

Infection with the pathogenic yeast fungus Candida auris (C. auris) can wreak havoc on the health of hospital patients and residents of nursing homes, especially those who are already weakened by ...

Pediatric Precision Medicine at the National Cancer Center Japan: Prospective Genomic Study of Pediatric Patients with Cancer as Part of the TOP-GEAR Project Several studies have indicated that broad ...

In 467 consecutive patients with ALL (0-20 years), we compared RNA sequencing (RNAseq), fluorescence in situ hybridization (FISH), reverse transcriptase polymerase chain reaction (RT-PCR), karyotyping ...

Growth, Share, Opportunities & Competitive Analysis, 2025 – 2032" report has been added to the Credence Research Inc. offering.

Dr. Bill Kerr, CEO and cofounder of Avalon Healthcare Solutions, works in what his company calls "diagnostic intelligence" – using real-time diagnostic data, advanced analytics and clear clinical ...